Literature DB >> 23103817

[Inflammatory cytokines in rheumatoid arthritis].

Miho Murakami1, Norihiro Nishimoto.   

Abstract

Dysregulation of cytokines, including tumor necrosis factor (TNF) and interleukin-6 (IL-6) , is involved in joint destruction in rheumatoid arthritis (RA) . TNF and IL-6 induce the differentiation and activation of osteoclasts. They also provide the formation of pannus through the synthesis of vascular endothelial growth factor (VEGF) . In addition, they contribute to the production of matrix metalloproteinases which digest collagen and proteoglycan of cartilage and bone. Biologic agents targeting these cytokines have provided beneficial outcomes, such as achievement of clinical remission, protective effects against joint destruction, and improvement in quality of life (QOL) in RA patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103817     DOI: CliCa121117371746

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  2 in total

1.  Swertiamarin ameliorates inflammation and osteoclastogenesis intermediates in IL-1β induced rat fibroblast-like synoviocytes.

Authors:  S Saravanan; V I Hairul Islam; K Thirugnanasambantham; N Pazhanivel; N Raghuraman; M Gabriel Paulraj; S Ignacimuthu
Journal:  Inflamm Res       Date:  2014-02-04       Impact factor: 4.575

2.  Anti-nociceptive effect of Portulaca oleracea L. ethanol extracts attenuated zymosan-induced mouse joint inflammation via inhibition of Nrf2 expression.

Authors:  Yunwu He; Hui Long; Cong Zou; Wuzhou Yang; Liping Jiang; Zhenping Xiao; Qing Li; Shiyin Long
Journal:  Innate Immun       Date:  2021-02-20       Impact factor: 2.680

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.